Prof Paddy Mallon

Paddy Mallon, MD, PhD, is Professor of Microbial Diseases at UCD School of Medicine and Consultant Physician in Infectious Diseases at St Vincent’s University Hospital (SVUH).

Prof Mallon is a world recognised scientist and physician with more than 18 years’ experience in HIV and Infectious Diseases research focused on HIV care and prevention.

He established the HIV Molecular Research Group (HMRG) in 2008, which is regarded as one of Europe’s leading research groups in translational research in HIV, and became Director of the Centre for Experimental Pathogen Host Research (CEPHR) in 2018, one of the few academic research centres in Europe that integrates host and pathogen research comprising clinical, translational, statistical and biomedical researchers working interactively on aspects of host and pathogen research.

In addition, Prof Mallon is Deputy Director of the Welcome Trust / HRB Irish Clinical Academic Training Programme, the foremost programme in Ireland coordinating integrated clinical and academic training. He is also heavily involved in guidelines and policy; he is the chair of the comorbidities panel of the European AIDS Clinical Society (EACS) and is a Regional Representative of EACS for Northern Europe. He has published more than one hundred peer-reviewed manuscripts and sits on the editorial board of AIDS, HIV Medicine and AIDS Research and Therapy.

Dr Eoin Feeney

Eoin Feeney graduated in Medicine from Trinity College Dublin in 2002. In 2012 he completed Higher Specialist Training in Infectious Diseases and General Internal Medicine through the Royal College of Physicians in Ireland, and in the same year was awarded a PhD examining the metabolic complications of HIV infection from University College Dublin. From 2012-2014 he undertook a Fellowship in Infectious Diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. From 2013-2014 he was an Instructor in Medicine at Harvard Medical School.

Dr Feeney’s areas of research at MGH/BWH were the mechanisms of accelerated fibrosis in HIV / hepatitis C virus co-infection. In 2014 he returned to Ireland as a Consultant Physician in Infectious Diseases and established the Infectious Diseases department at St. Vincent’s University Hospital where he is involved in the management of HIV and hepatitis C virus infection.

Dr Aoife Cotter

Aoife Cotter is Consultant in Infectious Diseases at the Mater Misericordiae and St Vincent’s University Hospitals.

Dr Cotter completed a PhD focusing on cohort methodology and bone disease in HIV under the supervision of Prof Paddy Mallon (HMRG/ University College Dublin) and Prof Caroline Sabin (Medical Statistics and Epidemiology, University College London). In addition to HIV UPBEAT, a longitudinal cohort exploring bone health, new research interests include exploring radiological and clinical changes in those undergoing contemporary hepatitis C treatment (The TRACER Cohort) and bone, kidney and gut microbiome alterations around antiretroviral therapy initiation (The BIGGER Study). Future, projects hope to exploit contemporary mobile health technologies to assess frailty and ultimately to promote healthy aging in people living with HIV.

Dr Virginie Gautier

Virginie Gautier leads a research group focused on the HIV-Host interface and HIV cure research at the UCD Centre for Experimental Pathogen Host Research (CEPHR).

Dr Gautier´s group has extensive expertise in molecular and cellular virology, epigenetics, patients’ cell-based assays, targeted drug screening and proteomic analysis. At the molecular level, the HIV-Host interface is a fundamental aspect of HIV/AIDS molecular pathogenesis. To delineate the intersection between HIV and cellular pathways, the group has developed innovative interdisciplinary approaches for target discovery. In addition and to expedite the translational continuum, they have developed a molecular pathway-driven translational research platform to facilitate drug screening and identify novel classes of latency-reversing drugs.

She has been awarded national competitive research grants from the Irish Health Research Board (HRB), the Irish Research Council (IRC) and Enterprise Ireland (EI) funding to develop her research program. She is the coordinator of the EU4HIVCURE research programme which was awarded H2020-MSCA-RISE-2015 to accelerate HIV Cure research in Europe.  

Dr Elena Alvarez

Elena Alvarez has a BSc in Pharmacy and obtained her PhD from the Universidad Complutense de Madrid, Spain, in 2014, focused on the Pharmacogenetics and Pharmacokinetics of HIV treatment.

Dr Alvarez joined the HIV Molecular Research Group in March 2014 and has been working as a research project coordinator since. Dr Alvarez leads and coordinates several HMRG-coordinated international clinical trials and is involved in managing international grants from the NIH (US) and H2020 (EU) programmes. 

With people living with HIV more often having longer and healthier lives, her research interests include integrative studies in which clinical aspects along with social domains and quality of life are all explored simultaneously. In addition, she is also involved in screening and testing programmes to promote awareness and engagement to care.